| First Author | Nižetić D | Year | 2012 |
| Journal | Nat Rev Cancer | Volume | 12 |
| Issue | 10 | Pages | 721-32 |
| PubMed ID | 22996602 | Mgi Jnum | J:188278 |
| Mgi Id | MGI:5440120 | Doi | 10.1038/nrc3355 |
| Citation | Nizetic D, et al. (2012) Tumorigenesis in Down's syndrome: big lessons from a small chromosome. Nat Rev Cancer 12(10):721-32 |
| abstractText | If assessed by a number of criteria for cancer predisposition, Down's syndrome (DS) should be an overwhelmingly cancer-prone condition. Although childhood leukaemias occur more frequently in DS, paradoxically, individuals with DS have a markedly lower incidence of most solid tumours. Understanding the mechanisms that are capable of overcoming such odds could potentially open new routes for cancer prevention and therapy. In this Opinion article, we discuss recent reports that suggest unique and only partially understood mechanisms behind this paradox, including tumour repression, anti-angiogenic effects and stem cell ageing and availability. |
